Name: NewGenIvf Group Limited (NIVF) Financial Statements
Creator: FinSpry

NewGenIvf Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

NewGenIvf Group Limited income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	5.43	5.14	5.94	4.12
Cost of Revenue	3.61	3.45	4.41	3.09
Gross Profit	1.83	1.68	1.54	1.02
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00
Selling, General & Administrative	2.99	1.64	1.14	0.83
Operating Expenses	2.99	1.64	1.14	0.83
Operating Income	-1.16	0.04	0.40	0.20
Other Income/Expense
Interest Income	0.01	0.00	0.00	0.00
Interest Expense	0.78	0.05	-0.08	-0.09
Other Income/Expense	0.97	0.11	0.02	0.05
Income
Income Before Tax	-0.96	0.11	0.34	0.16
Income Tax Expense	-0.49	0.00	0.21	0.29
Net Income	-0.52	0.13	0.46	0.00
Net Income - Continuous Operations	-0.47	0.11	0.14	-0.14
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	0.02	0.38	0.50	0.37
EBIT	-0.18	0.15	0.40	0.20
Depreciation & Amortization	0.21	0.23	0.10	0.17
Earnings Per Share
Basic EPS	-346.00	193.00	679.00	-1.00
Diluted EPS	-346.00	193.00	679.00	-1.00
Basic Shares Outstanding	0.00	0.00	0.00	0.00
Diluted Shares Outstanding	0.00	0.00	0.00	0.00